Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in ...

Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, ...

At the end of 2022, the last year for which CDC data was publicly available, there were 135,400 people living with HIV in ...

It was January 2020 when Janvier Igabe walked into a salon in Kigali for a haircut and noticed a beautiful woman, Josiane Tuyishimire. He was instantly drawn to her and told her he was interested in ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...

An AIDS drug already shown to help prevent spread of the virus in gay men also works for heterosexual men and women, two studies in Africa found.

Iraq has recorded a slight rise in HIV cases, with health officials warning that overseas travel and unregulated tattooing ...

Among 154 people with clade II mpox infections, 58% had at least one persistent sequelae, 56% of which were related to ...

The “enormous revelation” that drugs can be used to prevent catching HIV has benefitted millions and helped slash ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...